Funder
Mugla Sitki Kocman University Scientific Research Project Office
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference30 articles.
1. Hung DT, Rubin EJ. Chemical biology and bacteria: not simply a matter of life or death. Curr Opin Chem Biol. 2006;10:321–6.
2. Slepenkin A, Enquist PA, Hagglund U, de La Maza LM, Elofsson M, et al. Reversal of the anti chlamydial activity of putative type III secretion inhibitors by iron. Infect Immun. 2007;75:3478–89.
3. Tree JJ, Wang D, McInally C, Mahajan A, Layton A, et al. Characterization of the effects of salicylidene acylhydrazide compounds on type III secretion in Escherichia coli O157:H7. Infect Immun. 2009;77:4209–20.
4. Richardson D, Ponka P, Baker E. The effect of the iron (III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. Cancer Res. 1994;54:685–9.
5. Merlot AM, Kalinowski DS, Richardson DR. Novel chelators for cancer treatment: where are we now? Antioxid Redox Signal. 2013;18:973–1006.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献